Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Study of Adjuvanted C. difficile Vaccine in Healthy Adults
NCT02052726Phase 1Completed
- Sponsor
- Pfizer
- Start
- Jan 2014
- Primary completion
- May 2015
- Modality
- Vaccines & Immunotherapeutics, mRNA Therapeutics
- Countries
- 2
01
Overview
Phase 1, randomised, single-blind trial of Clostridium difficile vaccine in Clostridioides difficile infection (CDI) (2 arms), sponsored by Pfizer. Primary endpoints: Proportion of subjects reporting local reactions and Proportion of subjects reporting systemic events. Started Jan 2014; status: completed.
02
Drugs
Clostridium difficile vaccine
03
Conditions
Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT02052726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02052726.